Funding Status: M&A
Headquarters: Hangzhou, Zhejiang, China
Founded Date: 01.01.2015
Total Funding: $124 M
Technology: Immunotherapy
Employee Number: 51-100
Estimated Revenue: $1M to $10M
Industry: Early Drug Development